loading

Galmed Pharmaceuticals Ltd Borsa (GLMD) Ultime notizie

pulisher
Dec 08, 2025

Galmed to present data on Aramchol’s potential in liver cancer By Investing.com - Investing.com Canada

Dec 08, 2025
pulisher
Dec 08, 2025

Galmed to present data on Aramchol’s potential in liver cancer - Investing.com

Dec 08, 2025
pulisher
Dec 08, 2025

Galmed Pharmaceuticals’ Aramchol Abstract Accepted for HEP-DART 2025 Presentation - TipRanks

Dec 08, 2025
pulisher
Dec 08, 2025

Galmed Pharmaceuticals’ Aramchol abstract accepted for HEP-DART 2025 presentation - MSN

Dec 08, 2025
pulisher
Dec 08, 2025

Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting - Yahoo Finance

Dec 08, 2025
pulisher
Dec 05, 2025

Galmed receives patent for combination therapy in South Korea By Investing.com - Investing.com Nigeria

Dec 05, 2025
pulisher
Dec 05, 2025

Can Galmed Pharmaceuticals Ltd. (GPH) stock surprise with quarterly resultsBuy Signal & Weekly Breakout Watchlists - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Galmed Announces Grant of New Use Patents for the Combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra for Mash - marketscreener.com

Dec 04, 2025
pulisher
Dec 04, 2025

Galmed stock rises after patent grant for MASH combo therapy By Investing.com - Investing.com Nigeria

Dec 04, 2025
pulisher
Dec 04, 2025

Galmed stock rises after patent grant for MASH combo therapy - Investing.com

Dec 04, 2025
pulisher
Dec 04, 2025

Galmed receives patent for combination therapy in South Korea - Investing.com

Dec 04, 2025
pulisher
Dec 04, 2025

Galmed Pharmaceuticals Secures New Patent for Aramchol Combination Therapy - TipRanks

Dec 04, 2025
pulisher
Dec 04, 2025

Galmed announces grant of new use patents for the combination of Aramchol and Madrigal Pharmaceuticals - marketscreener.com

Dec 04, 2025
pulisher
Dec 04, 2025

Galmed Announces Grant of New Use Patents for the combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra (Resmetirom) for MASH - WV News

Dec 04, 2025
pulisher
Dec 04, 2025

Can Galmed Pharmaceuticals Ltd. (GPH) stock sustain free cash flowQuarterly Trade Review & Accurate Trade Setup Notifications - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Galmed Pharmaceuticals (NASDAQ:GLMD) Stock Passes Below 200-Day Moving Average – Should You Sell? - Defense World

Dec 04, 2025
pulisher
Dec 04, 2025

Is Galmed Pharmaceuticals Ltd. (GPH) stock supported by strong fundamentals2025 EndofYear Setup & Risk Managed Investment Signals - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Is Galmed Pharmaceuticals Ltd. (GPH) stock good for long term investing - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Can Galmed Pharmaceuticals Ltd. (GPH) stock attract ESG investmentsTrade Volume Summary & High Accuracy Investment Signals - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Galmed Pharmaceuticals Shares Edge Higher Following CEO’s Positive Update - MSN

Dec 02, 2025
pulisher
Dec 02, 2025

Galmed Pharmaceuticals Expands Aramchol’s Clinical Applications and Strengthens Financial Position - MSN

Dec 02, 2025
pulisher
Dec 02, 2025

Is Galmed Pharmaceuticals Ltd. (GPH) stock positioned for digital growth era2025 Trading Volume Trends & Real-Time Buy Signal Notifications - Newser

Dec 02, 2025
pulisher
Dec 01, 2025

Galmed reports $19.2 million cash position, advances Aramchol programs By Investing.com - Investing.com Nigeria

Dec 01, 2025
pulisher
Dec 01, 2025

Galmed Pharmaceuticals stock rises on CEO’s optimistic outlook By Investing.com - Investing.com Nigeria

Dec 01, 2025
pulisher
Dec 01, 2025

Galmed Pharmaceuticals stock rises on CEO’s optimistic outlook - Investing.com

Dec 01, 2025
pulisher
Dec 01, 2025

Galmed reports $19.2 million cash position, advances Aramchol programs - Investing.com

Dec 01, 2025
pulisher
Dec 01, 2025

Galmed Issues CEO Letter to Shareholders - Sahm

Dec 01, 2025
pulisher
Dec 01, 2025

Galmed Pharmaceuticals (GLMD) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025
pulisher
Dec 01, 2025

What drives Galmed Pharmaceuticals Ltd stock priceEx-Dividend Date Alerts & Fast Growing Portfolio Trading - earlytimes.in

Dec 01, 2025
pulisher
Nov 29, 2025

Is Galmed Pharmaceuticals Ltd. stock a defensive play in 2025Quarterly Trade Report & Consistent Profit Trading Strategies - BỘ NỘI VỤ

Nov 29, 2025
pulisher
Nov 29, 2025

Energy Moves: How interest rate cuts could boost Galmed Pharmaceuticals Ltd. stockJuly 2025 Institutional & High Accuracy Trade Signal Alerts - moha.gov.vn

Nov 29, 2025
pulisher
Nov 27, 2025

EV Market: How Galmed Pharmaceuticals Ltd. stock compares to growth peersJuly 2025 Action & Fast Gaining Stock Reports - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 27, 2025

Galmed Pharmaceuticals Ltd (GLMD) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews

Nov 27, 2025
pulisher
Nov 27, 2025

Galmed Pharmaceuticals: Q3 Earnings Snapshot - Stamford Advocate

Nov 27, 2025
pulisher
Nov 27, 2025

How Galmed Pharmaceuticals Ltd. stock compares to growth peersJuly 2025 Fed Impact & Capital Protection Trade Alerts - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 26, 2025

Galmed Pharmaceuticals Reports Q3 2025 Financials and Research Breakthroughs - TipRanks

Nov 26, 2025
pulisher
Nov 26, 2025

Galmed Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Nov 26, 2025
pulisher
Nov 26, 2025

Will Galmed Pharmaceuticals Ltd. stock outperform tech sector in 2025July 2025 Opening Moves & AI Forecast for Swing Trade Picks - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 25, 2025

MSN Money - MSN

Nov 25, 2025
pulisher
Nov 24, 2025

Galmed Pharmaceuticals Ltd. (GLMD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 24, 2025
$38.53
price up icon 0.42%
$98.38
price down icon 0.32%
$31.57
price up icon 0.83%
$93.57
price down icon 0.31%
biotechnology ONC
$300.09
price down icon 5.87%
$196.92
price down icon 1.22%
Capitalizzazione:     |  Volume (24 ore):